Skip to content
Screener

Thermo Fisher Scientific TMO Total Cost of Revenue

Discontinued — last reported Q1 '18

Total Cost of Revenue at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.56B-2.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$282.7M+1.2%
Revvity logo
RevvityRVTY
$323.46M+11.8%
Kewaunee Scientific Corporation logo
Kewaunee Scientific CorporationKEQU
$50.16M-5.6%
Danaher logo
DanaherDHR
$2.65B+10.0%
BioLife Solutions logo
BioLife SolutionsBLFS
$10M+37.9%

Segments

By segment

See full
Laboratory Products and Biopharma Services$4.76B+7.9%
Life Sciences Solutions$1B+17.4%
Analytical Instruments$876M+4.9%
Specialty Diagnostics$657M-3.2%

By product

See full
Service revenues$3.31B+10.3%

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.42B+21.1%
Enterprise value$248.54B+18.9%
P/E30.6×+3.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsSold.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 4, 2018. Open the filing →

Filed
May 4, 2018
Fiscal quarter
Q1 FY2018
Calendar quarter
Q1 2018
Accession
0000097745-18-000017

FAQ

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.